Hugo Sax - Infectious Diseases

Author Information

Hugo Sax is a prominent researcher in the field of Infectious Diseases, currently affiliated with the Division of Infectious Diseases and Hospital Epidemiology at the University Hospital Zurich in Zurich, Switzerland. His work primarily focuses on infection prevention and control, with a particular interest in the transmission dynamics of infectious agents in healthcare settings.

Research Contributions

Hugo Sax has made significant contributions to the understanding and prevention of infections in healthcare environments. His recent work includes innovative approaches such as the use of silica nanoparticles with encapsulated DNA to trace pathogen spread, and an exploration of hand hygiene improvement strategies through the 'My Five Moments' approach. Sax has also investigated issues such as the potential for false positives in SARS-CoV-2 testing and has contributed to international surveys on infection prevention practices. His research extends to understanding the transmission dynamics of methicillin-resistant Staphylococcus aureus and secondary attack rates of influenza in hospitals.

Aliases

Hugo Sax is also known in academic circles by the aliases H Sax and H. Sax.

Publication and Citation Metrics

Metric	Value
Citation Count	10,566
H-Index	49
Paper Count	200

Publications:

Silica nanoparticles with encapsulated DNA (SPED) to trace the spread of pathogens in healthcare

DOI: 10.1186/s13756-021-01041-3

Year: 2022

‘My Five Moments’: understanding a user-centred approach to hand hygiene improvement within a broader implementation strategy

DOI: 10.1136/bmjqs-2021-013680

Year: 2022

Do we cause false positives? An experimental series on droplet or airborne SARS-CoV-2 contamination of sampling tubes during swab collection in a test center

DOI: 10.1186/s13756-021-00920-z

Year: 2021

Documentation of Adherence To Infection Prevention Best Practice in Patient Records – A Mixed-Methods Investigation

DOI: 10.21203/rs.3.rs-1098981/v1

Year: 2021

Infection prevention practices in the United States, the Netherlands, Switzerland, and Japan: Results from national surveys

DOI: 10.1017/ice.2020.1395

Year: 2021

Understanding short-term transmission dynamics of methicillin-resistant Staphylococcus aureus in the patient room.

DOI: 10.1017/ice.2021.350

Year: 2021

Secondary attack rates from asymptomatic and symptomatic influenza virus shedders in hospitals: Results from the TransFLUas influenza transmission study

DOI: 10.1017/ice.2021.112

Year: 2021

What will infection prevention look like in 2030-results of the first round of a global crystal ball exercise

DOI: 10.1186/s13756-021-00974-z0

Year: 2021

The global outbreak of Mycobacterium chimaera infections in cardiac surgery - A systematic review of whole genome sequencing studies and joint analysis.

DOI: 10.1016/j.cmi.2021.07.017

Year: 2021

Implementation of daily chlorhexidine bathing in intensive care units for reduction of central line-associated bloodstream infections.

DOI: 10.1016/j.jhin.2021.01.007

Year: 2021

How Can Infectious Diseases Be Prevented?

What are Bacteria?

How Can Rabies Be Prevented?

Why is Understanding Airborne Transmission Important?

What Role Does Sanitization Play in Infection Control?

How are Structural Proteins Targeted in Vaccine Development?

How is Immunotherapy Used in Treating Infectious Diseases?

How is Rabies Diagnosed?

How is Zika Virus Diagnosed?

How is AIDS Diagnosed?

Partnered Content Networks

Relevant Topics